We are live on ! Find out more
ONCY

Oncolytics Biotech
ONCY

44 hedge funds and large institutions have $3.39M invested in Oncolytics Biotech in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

7% more funds holding

Funds holding: 41 → 44 (+3)

0.11% less ownership

Funds ownership: 2.04% → 1.93% (-0.11%)

12% less capital invested

Capital invested by funds: $3.87M → $3.39M (-$474K)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

Holders
44
Holders Change
+3
Holders Change %
+7.32%
% of All Funds
0.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$289K
2
TD Asset Management
TD Asset Management
Ontario, Canada
+$159K
3
VF
Virtu Financial
New York
+$109K
4
Two Sigma Investments
Two Sigma Investments
New York
+$77.2K
5
Renaissance Technologies
Renaissance Technologies
New York
+$70.4K

Top Sellers

Rank Fund Capital Flow
1
Creative Planning
Creative Planning
Kansas
-$648K
2
IAIM
International Assets Investment Management
Florida
-$355K
3
Citadel Advisors
Citadel Advisors
Florida
-$61.2K
4
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$60.8K
5
Squarepoint
Squarepoint
New York
-$44K
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
26
IFP Advisors
Florida
$14K – – –
TCOV
27
Trust Company of Vermont
Vermont
$14K – – –
ZB
28
Zions Bancorporation
Utah
$14K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$12K +$1.53K +500 +13%
FDCDDQ
30
Federation des caisses Desjardins du Quebec
Quebec, Canada
$9.34K -$16.1K -5,263 -61%
Toronto Dominion Bank
31
Toronto Dominion Bank
Ontario, Canada
$7K -$60.8K -19,865 -88%
HI
32
Harbour Investments
Wisconsin
$6K – – –
TRCT
33
Tower Research Capital (TRC)
New York
$6K +$6.62K +2,160 New
Wells Fargo
34
Wells Fargo
California
$4K +$306 +100 +7%
Fifth Third Bancorp
35
Fifth Third Bancorp
Ohio
$3K – – –
NFG
36
Next Financial Group
Texas
$3K – – –
SN
37
Sittner & Nelson
Oregon
$3K – – –
RDWM
38
Red Door Wealth Management
Tennessee
$2K +$3.06K +1,000 New
JFA
39
JNBA Financial Advisors
Minnesota
$1K – – –
Creative Planning
40
Creative Planning
Kansas
– -$648K -170,000 Closed
Squarepoint
41
Squarepoint
New York
– -$44K -11,650 Closed
Goldman Sachs
42
Goldman Sachs
New York
– -$39K -10,300 Closed
Deutsche Bank
43
Deutsche Bank
Germany
– -$29K -7,600 Closed
SWM
44
Spire Wealth Management
Virginia
– -$4K -1,000 Closed
CAPTRUST Financial Advisors
45
CAPTRUST Financial Advisors
North Carolina
– -$1.53K -500 -100%
Fidelity Investments
46
Fidelity Investments
Massachusetts
– +$3 +1 New
1
2

ONCY Hedge Fund Activity: Q2 2021 in Review

44 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q2 2021, worth a combined $3.39M — down 12% from $3.87M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ONCY positions and 5 closed out — a net gain of 3 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $289K. The largest seller was Creative Planning, exiting entirely with an estimated $648K sold.

  • 44 institutional investors held Oncolytics Biotech (ONCY) as of Q2 2021, up from 41 in Q1 2021.
  • Funds reported $3.39M of Oncolytics Biotech stock for Q2 2021, down 12% quarter-over-quarter.
  • 8 funds opened new Oncolytics Biotech positions in Q2 2021 and 5 closed out, a net change of +3 holders.
  • The largest Oncolytics Biotech buyer in Q2 2021 was JP Morgan Chase, an estimated $289K added.
  • The largest Oncolytics Biotech seller in Q2 2021 was Creative Planning, an estimated $648K sold.

Based on aggregated 13F filings for Q2 2021.